Across
- 3. route of admin of denosumab
- 5. decoy receptor
- 8. sensory neuropathy theory
- 9. Tx for postmenooausal osteoporosis (PMO)
- 10. monoclonocal antibody
- 11. 1st line therapy for PMO
- 12. superfamily
Down
- 1. autonomic neuropathy theory
- 2. RANKL functions in
- 4. Tx for Giant Cell Tumor
- 6. large osteoporosis study with denosumab
- 7. secretes RANKL and OPG